PHARMACEUTICAL & BIOTECH RESULTS - FEW EXAMPLES

IMI’s advisory and “hands-on” strategic support have resulted in the following for its Clients:

Marketing Strategies/Implementation

• Conducted numerous “repositionings” of technologies resulting in value-creation for deal-making and investments (6-7 cancer, epilepsy, drug delivery, etc. technologies)
• HC Division becoming the no. 1 profit provider in its conglomerate
• Achievement of market leadership in Europe and the U.S.A. for a CNS product
• European strategy and sales call target development for a major drug delivery company resulting in significant sales increase

IMI’s transaction-oriented consulting has resulted in the following for its Clients:

Business Development & Licensing, M&A, Capital Raising

• Divestiture of a GI company for 136 Mio CHF
  
• Completed or influenced 60 transactions for Clients in Biotech, Pharma and Diagnostics having negotiated ca. 100 transactions (Core BD Team)
  
• Concluded a reputable biotech R&D collaboration, assuring the Client’s closure of successful financing rounds
• Completed a 7-country European alliance having a value of 1.1 Billion USD (discounted)
• Raised capital for creation of a U.S.A. Biotech Fund, helped set-up Fund
• Raised capital for 2 Biotech companies